Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC), a blank-check company sponsored by Amplitude Healthcare LLC, completed its initial public offering in January 2021 targeting the healthcare and biopharmaceutical sector. The company filed an 8-K on September 23, 2021, reporting a material development related to its proposed business combination with Jasper Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on hematopoietic stem cell transplantation and conditioning therapies. The transaction ultimately closed in 2022, with the combined company carrying forward the Jasper Therapeutics name and continuing to trade on Nasdaq under an updated ticker. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal-timeline data on this and every active SPAC.